Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$237K Buy
+2,279
New +$220K 0.01% 567
2021
Q3
Sell
-10,429
Closed -$1.43M 686
2021
Q2
$1.43M Buy
+10,429
New +$1.43M 0.02% 251
2017
Q3
Sell
-1,007
Closed -$51K 466
2017
Q2
$51K Buy
+1,007
New +$49.8K ﹤0.01% 329
2016
Q4
$17K Sell
405
-295
-42% -$12.5K 0.08% 62
2016
Q3
$28K Buy
+700
New +$29.7K 0.06% 70
2016
Q1
$27K Buy
+602
New +$23.6K 0.02% 386

Other funds holding CNMD

ETF Managers Group's CNMD Position: Q1 2023 in Review

ETF Managers Group opened a new position in CONMED (CNMD) in Q1 2023: 2,279 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #567 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in CNMD as recently as Q2 2021.

ETF Managers Group first reported a position in CNMD in Q1 2016 and has held it in 6 quarters since. The position peaked at $1.43M in Q2 2021. 232 funds tracked by Wall St. Rank hold CNMD as of Q1 2023.

  • ETF Managers Group held 2,279 shares of CONMED worth $237K as of Q1 2023.
  • CONMED was a new ETF Managers Group position in Q1 2023.
  • CONMED made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #567 holding.
  • ETF Managers Group first reported a position in CONMED in Q1 2016 and has held it in 6 quarters since.
  • ETF Managers Group's CONMED position peaked at $1.43M in Q2 2021.
  • 232 funds tracked by Wall St. Rank held CONMED as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.